| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.14B | +9.0% |
| Cost of Revenue | $655.8M | +8.6% |
| Gross Profit | $487.5M | +9.6% |
| R&D Expense | $13.3M | +22.0% |
| SG&A Expense | $323.4M | +9.1% |
| Operating Income | $161.6M | +13.6% |
| Pre-tax Income | $57.6M | -39.0% |
| Income Tax | $17.1M | -20.5% |
| Net Income | $40.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.7M | -51.5% |
| Inventory | $153.8M | +10.8% |
| Current Assets | $437.7M | -14.6% |
| Total Assets | $2.66B | +6.9% |
| Current Liabilities | $188.7M | -4.7% |
| Long-term Debt | $655.3M | +2.4% |
| Total Liabilities | $1.12B | +5.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $42.0M | +44.3% |
| Investing Cash Flow | -$316.9M | -31.2% |
| Financing Cash Flow | -$17.4M | +65.5% |
| -44.4% |
| EPS (Basic) | $1.92 | -44.8% |
| EPS (Diluted) | $1.91 | -44.6% |
| Stockholders' Equity |
| $1.54B |
| +8.1% |